Becton, Dickinson in $85M settlement over failure to disclose defects with infusion pumps
Becton, Dickinson (NYSE:BDX), or BD, on Thursday said it had agreed to pay $85M to settle claims that it had failed to ...
Benzinga.com18d
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
The Becton, Dickinson and Company BDX spin-off announced that it decided to discontinue its insulin patch pump program and plans to initiate a restructuring plan. In July, Embecta, a manufacturer ...
Reuters5mon
Becton Dickinson And Co
Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices. Becton Dickinson beats quarterly estimates on ...
Nature23y
Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment
4–15 weeks after BM transplant, peripheral-blood was examined by FACS (Becton Dickinson, Heidelberg, Germany). After erylysis, cells labeled with Mac-1-Pe, B220-Pe, Gr-1-Pe and CD4-Pe ...